Patrizia Cavazzoni, formerly the top regulator of the drug division of the FDA, will join Pfizer as chief medical officer.
An approval for the first drug for a rare lipid storage disease, some FDA workers rehired, and other biotech news of the day ...
Staff units evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though ...
The chief said the loss of critical employees overseeing the nation’s food supply made his work impossible. Robert F. Kennedy ...
Experts say that for decades, a legal loophole has allowed companies to include chemical additives that could be potentially ...
The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...
The Food and Drug Administration, or FDA, is responsible for regulating food and health-related products to ensure they're ...
The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this ...
The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper ...
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
Aveo Pharmaceuticals is accused of illegally exporting banned combination of tapentadol and carisoprodol to Nigeria, Ghana ...